Cadence Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.51M Sell
261,420
-27,740
-10% -$700K 0.38% 58
2025
Q3
$7.37M Sell
289,160
-643
-0.2% -$15.9K 0.45% 50
2025
Q2
$7.02M Buy
289,803
+30,632
+12% +$714K 0.46% 50
2025
Q1
$6.57M Buy
259,171
+290
+0.1% +$7.59K 0.47% 49
2024
Q4
$6.87M Sell
258,881
-70,812
-21% -$1.92M 0.47% 44
2024
Q3
$9.5M Buy
329,693
+54,490
+20% +$1.59M 0.66% 34
2024
Q2
$7.7M Buy
275,203
+5,079
+2% +$140K 0.58% 37
2024
Q1
$7.5M Sell
270,124
-18,891
-7% -$524K 0.55% 42
2023
Q4
$8.32M Buy
289,015
+203,084
+236% +$6.14M 0.68% 35
2023
Q3
$2.85M Sell
85,931
-6,792
-7% -$240K 0.25% 81
2023
Q2
$3.4M Sell
92,723
-2,490
-3% -$96.9K 0.3% 73
2023
Q1
$3.88M Buy
95,213
+2,583
+3% +$112K 0.36% 67
2022
Q4
$4.75M Sell
92,630
-558
-0.6% -$26.8K 0.44% 54
2022
Q3
$4.08M Buy
93,188
+75,415
+424% +$3.66M 0.42% 60
2022
Q2
$932K Sell
17,773
-933
-5% -$47.5K 0.13% 85
2022
Q1
$968K Sell
18,706
-830
-4% -$43.1K 0.12% 93
2021
Q4
$1.15M Sell
19,536
-2,210
-10% -$109K 0.14% 88
2021
Q3
$935K Sell
21,746
-1,030
-5% -$45.6K 0.13% 94
2021
Q2
$892K Buy
22,776
+330
+1% +$12.8K 0.13% 96
2021
Q1
$813K Sell
22,446
-153,514
-87% -$5.45M 0.12% 104
2020
Q4
$6.48M Buy
175,960
+17,680
+11% +$649K 1.02% 26
2020
Q3
$5.81M Sell
158,280
-3,936
-2% -$145K 1.14% 21
2020
Q2
$5.3M Buy
162,216
+1,740
+1% +$62.3K 1.09% 23
2020
Q1
$5.24M Buy
160,476
+36,073
+29% +$1.3M 1.32% 18
2019
Q4
$4.87M Buy
124,403
+10,862
+10% +$408K 0.9% 27
2019
Q3
$4.08M Buy
113,541
+6,118
+6% +$234K 0.38% 47
2019
Q2
$4.65M Buy
107,423
+6,926
+7% +$290K 0.45% 38
2019
Q1
$4.27M Buy
100,497
+2,116
+2% +$89.3K 0.43% 36
2018
Q4
$4.3M Buy
98,381
+8,346
+9% +$365K 0.51% 28
2018
Q3
$3.97M Buy
90,035
+1,645
+2% +$66.7K 0.37% 36
2018
Q2
$3.21M Buy
88,390
+1,544
+2% +$55.6K 0.29% 51
2018
Q1
$3.08M Buy
86,846
+2,202
+3% +$79.8K 0.3% 51
2017
Q4
$3.07M Buy
84,644
+181
+0.2% +$6.5K 0.29% 48
2017
Q3
$3.02M Buy
84,463
+1,883
+2% +$63.8K 0.3% 49
2017
Q2
$2.77M Buy
82,580
+1,642
+2% +$54.6K 0.28% 52
2017
Q1
$2.77M Buy
80,938
+765
+1% +$25.4K 0.29% 49
2016
Q4
$2.6M Buy
80,173
+6,049
+8% +$195K 0.29% 50
2016
Q3
$2.51M Buy
74,124
+2,645
+4% +$93.2K 0.27% 49
2016
Q2
$2.52M Buy
71,479
+1,468
+2% +$49.4K 0.28% 49
2016
Q1
$2.08M Buy
70,011
+53,745
+330% +$1.62M 0.25% 58
2015
Q4
$525K Sell
16,266
-3,377
-17% -$112K 0.06% 129
2015
Q3
$617K Buy
19,643
+1,815
+10% +$61.3K 0.08% 116
2015
Q2
$597K Buy
17,828
+4,915
+38% +$169K 0.07% 122
2015
Q1
$449K Sell
12,913
-168
-1% -$5.63K 0.05% 139
2014
Q4
$408K Sell
13,081
-8,439
-39% -$255K 0.04% 154
2014
Q3
$637K Sell
21,520
-654
-3% -$19.3K 0.07% 121
2014
Q2
$658K Buy
22,174
+1,805
+9% +$54.2K 0.07% 121
2014
Q1
$654K Buy
20,369
+7,326
+56% +$230K 0.07% 119
2013
Q4
$399K Buy
13,043
+152
+1% +$4.66K 0.04% 161
2013
Q3
$370K Sell
12,891
-720
-5% -$20.6K 0.04% 157
2013
Q2
$381K Hold
13,611
– – 0.05% 153

Other funds holding PFE

Cadence Bank's PFE Position: Q4 2025 in Review

Cadence Bank reduced its Pfizer (PFE) stake by 9.6% in Q4 2025, selling an estimated $700K and leaving 261,420 shares worth $6.51M. The position accounts for 0.38% of the portfolio, ranked #58.

Cadence Bank first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $9.5M in Q3 2024. 2,932 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Cadence Bank held 261,420 shares of Pfizer worth $6.51M as of Q4 2025.
  • Cadence Bank sold 27,740 Pfizer shares in Q4 2025, an estimated $700K.
  • Pfizer made up 0.38% of Cadence Bank's portfolio in Q4 2025, its #58 holding.
  • Cadence Bank first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Cadence Bank's Pfizer position peaked at $9.5M in Q3 2024.
  • 2,932 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.